Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction.
Ontoria JM, Biancofiore I, Fezzardi P, Ferrigno F, Torrente E, Colarusso S, Bianchi E, Andreini M, Patsilinakos A, Kempf G, Augustin M, Steinbacher S, Summa V, Pacifici R, Muñoz-Sanjuan I, Park L, Bresciani A, Dominguez C, Sherman LT, Harper S. Ontoria JM, et al. Among authors: patsilinakos a. ACS Med Chem Lett. 2020 Apr 3;11(5):740-746. doi: 10.1021/acsmedchemlett.9b00594. eCollection 2020 May 14. ACS Med Chem Lett. 2020. PMID: 32435379 Free PMC article.
Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators.
Ivanova Bencheva L, Donnici L, Ferrante L, Prandi A, Sinisi R, De Matteo M, Randazzo P, Conti M, Di Lucia P, Bono E, Giustini L, Vittoria Orsale M, Patsilinakos A, Monteagudo E, Iannacone M, Summa V, Guidotti LG, De Francesco R, Di Fabio R. Ivanova Bencheva L, et al. Among authors: patsilinakos a. Bioorg Med Chem Lett. 2022 Oct 1;73:128904. doi: 10.1016/j.bmcl.2022.128904. Epub 2022 Jul 19. Bioorg Med Chem Lett. 2022. PMID: 35868496
Novel coumarin- and quinolinone-based polycycles as cell division cycle 25-A and -C phosphatases inhibitors induce proliferation arrest and apoptosis in cancer cells.
Zwergel C, Czepukojc B, Evain-Bana E, Xu Z, Stazi G, Mori M, Patsilinakos A, Mai A, Botta B, Ragno R, Bagrel D, Kirsch G, Meiser P, Jacob C, Montenarh M, Valente S. Zwergel C, et al. Among authors: patsilinakos a. Eur J Med Chem. 2017 Jul 7;134:316-333. doi: 10.1016/j.ejmech.2017.04.012. Epub 2017 Apr 10. Eur J Med Chem. 2017. PMID: 28431339
Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M, Patsilinakos A, Pirolli A, Sabatino M, Ragno R. Mladenović M, et al. Among authors: patsilinakos a. J Chem Inf Model. 2017 Apr 24;57(4):787-814. doi: 10.1021/acs.jcim.6b00608. Epub 2017 Mar 30. J Chem Inf Model. 2017. PMID: 28291352
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity.
Carradori S, Bizzarri B, D'Ascenzio M, De Monte C, Grande R, Rivanera D, Zicari A, Mari E, Sabatino M, Patsilinakos A, Ragno R, Secci D. Carradori S, et al. Among authors: patsilinakos a. Eur J Med Chem. 2017 Nov 10;140:274-292. doi: 10.1016/j.ejmech.2017.09.026. Epub 2017 Sep 19. Eur J Med Chem. 2017. PMID: 28963991
Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cells.
Stazi G, Battistelli C, Piano V, Mazzone R, Marrocco B, Marchese S, Louie SM, Zwergel C, Antonini L, Patsilinakos A, Ragno R, Viviano M, Sbardella G, Ciogli A, Fabrizi G, Cirilli R, Strippoli R, Marchetti A, Tripodi M, Nomura DK, Mattevi A, Mai A, Valente S. Stazi G, et al. Among authors: patsilinakos a. Eur J Med Chem. 2019 Feb 1;163:722-735. doi: 10.1016/j.ejmech.2018.11.050. Epub 2018 Nov 28. Eur J Med Chem. 2019. PMID: 30576903
Decreasing acidity in a series of aldose reductase inhibitors: 2-Fluoro-4-(1H-pyrrol-1-yl)phenol as a scaffold for improved membrane permeation.
Chatzopoulou M, Patsilinakos A, Vallianatou T, Prnova MS, Zakelj S, Ragno R, Stefek M, Kristl A, Tsantili-Kakoulidou A, Demopoulos VJ. Chatzopoulou M, et al. Among authors: patsilinakos a. Bioorg Med Chem. 2014 Apr 1;22(7):2194-207. doi: 10.1016/j.bmc.2014.02.016. Epub 2014 Feb 26. Bioorg Med Chem. 2014. PMID: 24630695
Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylation.
Papastavrou N, Chatzopoulou M, Ballekova J, Cappiello M, Moschini R, Balestri F, Patsilinakos A, Ragno R, Stefek M, Nicolaou I. Papastavrou N, et al. Among authors: patsilinakos a. Eur J Med Chem. 2017 Apr 21;130:328-335. doi: 10.1016/j.ejmech.2017.02.053. Epub 2017 Feb 24. Eur J Med Chem. 2017. PMID: 28259841
27 results